data_2knn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2knn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 2' ' ' ILE . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 121.276 0.56 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.711 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.65 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.176 0.512 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.479 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 26' ' ' VAL . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 25' ' ' LYS . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.026 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.026 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.38 0.609 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.728 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 22' ' ' CYS . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 14' ' ' ILE . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 23' ' ' LYS . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.339 0.59 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.065 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.065 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 23' ' ' LYS . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.438 0.637 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.69 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 18' ' ' ILE . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 2' ' ' ILE . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.192 0.52 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 11' ' ' ILE . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.5 HG23 ' HD2' ' A' ' 3' ' ' PRO . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 2' ' ' ILE . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 121.075 0.464 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 11' ' ' ILE . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.324 0.583 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.696 HG21 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.545 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.621 0.724 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.413 0.625 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.735 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 121.448 0.642 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.322 0.582 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 18' ' ' ILE . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' HG21 ' A' ' 26' ' ' VAL . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' HG12 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 23' ' ' LYS . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 121.31 0.576 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.902 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.797 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.902 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 27' ' ' CYS . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' N ' HG13 ' A' ' 26' ' ' VAL . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.324 0.583 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.858 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 11' ' ' ILE . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 16' ' ' SER . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 14' ' ' ILE . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD11 HG21 ' A' ' 18' ' ' ILE . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.858 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.125 0.488 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.738 HG23 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 18' ' ' ILE . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' O ' HG11 ' A' ' 26' ' ' VAL . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.601 HG11 ' O ' ' A' ' 23' ' ' LYS . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 2' ' ' ILE . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 2' ' ' ILE . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.274 0.559 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.845 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 11' ' ' ILE . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.529 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.629 HG21 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.629 ' H ' HG21 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.362 0.601 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.875 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 18' ' ' ILE . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 15' ' ' SER . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.875 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.634 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.555 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.18 -46.33 0.73 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.481 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -97.46 166.39 11.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.278 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 2' ' ' ILE . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.14 34.93 87.74 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -86.24 177.24 7.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.208 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.711 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.439 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.65 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.07 -43.36 1.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -85.03 175.94 8.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.661 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.479 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 26' ' ' VAL . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 25' ' ' LYS . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.13 -40.49 1.55 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.493 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.91 174.26 8.84 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.263 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.026 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.026 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.73 33.22 66.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 177.12 7.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.5 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.728 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 22' ' ' CYS . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 14' ' ' ILE . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 23' ' ' LYS . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.96 33.34 70.13 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -84.37 175.99 8.99 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.07 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.065 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.065 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 23' ' ' LYS . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.98 -48.49 0.5 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -82.49 178.63 8.12 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.722 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 18' ' ' ILE . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 2' ' ' ILE . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.75 36.18 86.85 Favored Glycine 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.83 174.77 7.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.657 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 11' ' ' ILE . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.514 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.5 HG23 ' HD2' ' A' ' 3' ' ' PRO . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 2' ' ' ILE . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.11 -41.63 1.38 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.11 174.79 9.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.93 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 11' ' ' ILE . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.65 32.05 67.5 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.34 173.71 9.53 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.33 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.696 HG21 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.545 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.92 -46.74 0.41 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.407 ' H1G' ' O ' ' A' ' 7' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m -77.6 -177.69 4.91 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.753 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.46 30.01 73.13 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.0 175.82 7.25 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.112 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.735 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.735 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.66 38.08 77.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.521 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.86 173.5 8.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.985 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.7 38.74 67.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.424 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -90.19 175.23 7.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 18' ' ' ILE . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' HG21 ' A' ' 26' ' ' VAL . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' HG12 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 23' ' ' LYS . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.424 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.24 -46.42 0.72 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.638 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.32 175.62 7.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.36 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.902 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.797 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' H3X' ' A' ' 6' ' ' GME . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.902 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 27' ' ' CYS . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.27 32.95 72.57 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -92.9 176.1 6.55 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.196 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.858 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 11' ' ' ILE . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 16' ' ' SER . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 14' ' ' ILE . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD11 HG21 ' A' ' 18' ' ' ILE . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.858 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.76 -35.13 3.52 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 175.72 10.13 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.695 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.738 HG23 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 18' ' ' ILE . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' O ' HG11 ' A' ' 26' ' ' VAL . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.738 ' HB3' HG23 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.601 HG11 ' O ' ' A' ' 23' ' ' LYS . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 2' ' ' ILE . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 2' ' ' ILE . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.0 -28.39 13.21 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.575 ' H1G' ' HB2' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.87 171.72 11.29 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.133 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.845 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 11' ' ' ILE . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.529 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.629 HG21 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.629 ' H ' HG21 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.575 ' HB2' ' H1G' ' A' ' 6' ' ' GME . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.01 -47.13 0.65 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GME . . . . . 0.643 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.99 176.88 8.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.875 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 18' ' ' ILE . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 15' ' ' SER . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.875 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.634 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.6 -40.81 1.48 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -91.57 166.01 13.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.914 178.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.555 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 121.276 0.56 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.716 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.498 ' CD1' HG12 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.176 0.512 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 18' ' ' ILE . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 14' ' ' ILE . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.64 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.38 0.609 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.648 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.339 0.59 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.068 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.531 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 23' ' ' LYS . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.438 0.637 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.192 0.52 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HD1' ' A' ' 10' ' ' TRP . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.555 ' HD1' HG12 ' A' ' 9' ' ' VAL . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 28' ' ' TYR . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 121.075 0.464 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 9' ' ' VAL . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.726 HG21 ' HB2' ' A' ' 13' ' ' CYS . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.324 0.583 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.677 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.621 0.724 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.413 0.625 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.664 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.664 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.738 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.738 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' ASN . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 121.448 0.642 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.443 ' CD1' HG12 ' A' ' 9' ' ' VAL . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 20' ' ' CYS . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.322 0.582 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 121.31 0.576 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.408 ' HD1' HG12 ' A' ' 9' ' ' VAL . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 18' ' ' ILE . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 14' ' ' ILE . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.913 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.324 0.583 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.898 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.652 ' HD1' HG12 ' A' ' 9' ' ' VAL . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.898 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.125 0.488 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.767 ' HB3' HG22 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.274 0.559 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.876 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.764 HG23 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.764 ' H ' HG23 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.362 0.601 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.897 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.897 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.18 -46.33 0.73 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.502 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -97.46 166.39 11.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.278 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.14 34.93 87.74 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -86.24 177.24 7.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.208 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.716 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.498 ' CD1' HG12 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.07 -43.36 1.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.406 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -85.03 175.94 8.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.661 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 18' ' ' ILE . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 14' ' ' ILE . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.13 -40.49 1.55 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.508 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.91 174.26 8.84 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.263 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.64 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.508 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.73 33.22 66.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 177.12 7.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.5 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.648 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.96 33.34 70.13 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -84.37 175.99 8.99 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.07 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.068 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.531 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 23' ' ' LYS . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.98 -48.49 0.5 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 m -82.49 178.63 8.12 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.722 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.75 36.18 86.85 Favored Glycine 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -91.83 174.77 7.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.657 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HD1' ' A' ' 10' ' ' TRP . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.555 ' HD1' HG12 ' A' ' 9' ' ' VAL . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 28' ' ' TYR . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.11 -41.63 1.38 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.11 174.79 9.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.93 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 9' ' ' VAL . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.726 HG21 ' HB2' ' A' ' 13' ' ' CYS . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.65 32.05 67.5 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.34 173.71 9.53 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.33 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.677 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.92 -46.74 0.41 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.461 ' H2X' ' SG ' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m -77.6 -177.69 4.91 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.753 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 HG13 ' H1X' ' A' ' 6' ' ' GME . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' H2X' ' A' ' 6' ' ' GME . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.46 30.01 73.13 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.0 175.82 7.25 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.112 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.664 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.664 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.738 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.738 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' ASN . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.66 38.08 77.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.527 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.86 173.5 8.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.985 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.443 ' CD1' HG12 ' A' ' 9' ' ' VAL . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 20' ' ' CYS . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.7 38.74 67.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.43 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -90.19 175.23 7.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.24 -46.42 0.72 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.654 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.32 175.62 7.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.36 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.408 ' HD1' HG12 ' A' ' 9' ' ' VAL . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 18' ' ' ILE . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 14' ' ' ILE . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.913 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.654 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.27 32.95 72.57 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -92.9 176.1 6.55 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.196 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.898 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.652 ' HD1' HG12 ' A' ' 9' ' ' VAL . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.898 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.76 -35.13 3.52 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 175.72 10.13 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.695 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.767 ' HB3' HG22 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.0 -28.39 13.21 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.595 ' H1G' ' HB2' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.87 171.72 11.29 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.133 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.876 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.764 HG23 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.764 ' H ' HG23 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' H1G' ' A' ' 6' ' ' GME . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.01 -47.13 0.65 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GME . . . . . 0.659 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.99 176.88 8.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.897 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.897 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.659 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.6 -40.81 1.48 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -91.57 166.01 13.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.914 178.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 121.276 0.56 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.716 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.498 ' CD1' HG12 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.176 0.512 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 18' ' ' ILE . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 14' ' ' ILE . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.64 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.38 0.609 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.648 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 121.339 0.59 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.068 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.531 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 23' ' ' LYS . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.438 0.637 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.192 0.52 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HD1' ' A' ' 10' ' ' TRP . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.555 ' HD1' HG12 ' A' ' 9' ' ' VAL . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 28' ' ' TYR . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 121.075 0.464 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 9' ' ' VAL . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.726 HG21 ' HB2' ' A' ' 13' ' ' CYS . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.324 0.583 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.677 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.621 0.724 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.413 0.625 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.664 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.664 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.738 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.738 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' ASN . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 121.448 0.642 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.443 ' CD1' HG12 ' A' ' 9' ' ' VAL . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 20' ' ' CYS . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.322 0.582 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 121.31 0.576 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.408 ' HD1' HG12 ' A' ' 9' ' ' VAL . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 18' ' ' ILE . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 14' ' ' ILE . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.913 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.324 0.583 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.898 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.652 ' HD1' HG12 ' A' ' 9' ' ' VAL . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.898 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.125 0.488 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.767 ' HB3' HG22 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.274 0.559 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.876 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.764 HG23 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.764 ' H ' HG23 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.362 0.601 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.897 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.897 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.285 0.074 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -138.58 136.61 19.05 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.37 142.85 98.01 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 121.912 1.741 . . . . 0.0 112.15 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 75.7 m -84.81 -46.55 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.464 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.18 -46.33 0.73 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.005 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.502 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -97.46 166.39 11.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.278 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.3 p -130.62 41.22 3.41 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.758 0.789 . . . . 0.0 109.09 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 21.6 t -65.78 -44.78 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -110.29 -57.68 2.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.96 123.91 40.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.982 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.24 147.52 37.6 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.797 2.332 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 1.8 p -87.16 53.69 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' SER . 49.4 mm -109.3 -52.18 6.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.281 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -71.13 23.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.208 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' ILE . 4.8 p -124.08 -12.1 7.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.125 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.93 39.93 30.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.066 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.3 -32.11 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.799 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.72 38.04 6.69 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 99.1 m -116.0 151.02 36.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.043 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -103.11 135.73 44.23 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -80.52 118.57 22.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -145.72 129.23 16.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 m 57.33 36.27 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.815 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 9' ' ' VAL . 13.2 mmmm 58.89 25.75 14.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.586 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 22.5 m -138.06 150.57 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 64.7 m -88.84 135.45 33.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 112.463 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -131.85 155.2 48.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.673 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttt85 -150.75 136.43 18.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.472 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.655 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.811 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.9 152.38 74.01 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 117.737 0.768 . . . . 0.0 109.494 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.73 144.29 88.75 Favored 'Trans proline' 0 C--N 1.333 -0.262 0 C-N-CA 121.729 1.619 . . . . 0.0 112.568 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 77.9 m -85.53 6.96 24.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.79 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.14 34.93 87.74 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.863 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -86.24 177.24 7.56 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.208 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.7 t -150.26 54.69 0.92 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.716 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 15.7 t -63.37 -44.42 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.195 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.498 ' CD1' HG12 ' A' ' 9' ' ' VAL . 87.8 m95 -144.16 -49.45 0.28 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.997 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.53 124.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.919 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' A' ' 14' ' ' ILE . 58.8 Cg_endo -71.93 147.03 48.75 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.709 2.273 . . . . 0.0 111.838 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -86.34 61.85 7.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 18' ' ' ILE . 51.1 mm -97.16 -53.5 7.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.845 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.4 m 65.95 -49.58 0.41 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.182 1.552 . . . . 0.0 112.164 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p -170.25 -36.29 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.48 46.15 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.178 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 14' ' ' ILE . 46.8 mm -66.72 -43.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.255 0.55 . . . . 0.0 109.895 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.37 41.41 13.53 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.86 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 63.9 m -101.4 148.22 25.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.349 0.595 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -93.36 126.04 38.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.273 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 t -87.48 122.96 31.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 13.8 pttp -150.96 131.2 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m 53.09 40.25 30.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.432 0.634 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 22.7 mttp 58.86 30.95 20.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.385 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -143.03 135.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 90.7 m -92.93 139.38 30.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.573 0.701 . . . . 0.0 112.553 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -131.54 154.06 49.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.324 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 16.1 ttt-85 -151.8 140.49 20.81 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.069 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.932 179.679 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -142.92 152.93 60.06 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 117.584 0.692 . . . . 0.0 109.48 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.33 145.24 88.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.767 1.645 . . . . 0.0 112.347 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.4 -42.82 15.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.093 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.07 -43.36 1.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.256 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.406 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -85.03 175.94 8.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.661 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 39.5 t -144.48 43.14 1.39 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.374 1.083 . . . . 0.0 108.843 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 17.0 t -72.88 -43.3 60.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.267 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -125.76 -49.58 1.62 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.938 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.0 pt -76.44 139.18 67.47 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.548 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.2 157.34 41.97 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.929 2.42 . . . . 0.0 111.973 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 73.6 m -85.75 63.93 8.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.504 0.669 . . . . 0.0 111.236 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 18' ' ' ILE . 65.7 mt -127.78 -59.22 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.203 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m 67.27 -48.95 0.49 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.848 1.343 . . . . 0.0 111.668 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.0 p -169.42 -37.65 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.136 0.974 . . . . 0.0 108.478 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 168.36 47.73 0.0 OUTLIER 'General case' 0 C--N 1.348 0.543 0 O-C-N 124.162 0.914 . . . . 0.0 110.859 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 14' ' ' ILE . 36.9 pt -72.01 -30.69 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 37.84 40.97 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.791 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.0 m -105.81 151.7 24.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.269 0.557 . . . . 0.0 109.88 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.6 p -106.95 133.93 50.87 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 t -73.29 124.95 26.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.081 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -148.33 130.73 15.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.7 p 47.97 43.64 17.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.605 0.717 . . . . 0.0 111.871 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 64.4 mmtt 59.22 28.85 18.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.476 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 14.7 m -146.44 157.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 71.2 m -88.93 136.06 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.286 0.565 . . . . 0.0 112.145 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.607 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -151.53 144.27 24.37 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.343 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.935 179.848 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.6 pt -142.05 152.2 61.06 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.562 0.681 . . . . 0.0 109.556 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 143.0 73.82 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.84 1.693 . . . . 0.0 112.323 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.9 m -85.05 -41.99 15.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.13 -40.49 1.55 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.917 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.508 ' OE2' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.91 174.26 8.84 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.263 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.5 t -139.76 32.35 2.02 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.308 1.051 . . . . 0.0 108.381 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.044 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.2 t -73.84 -53.97 16.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.483 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -87.5 -52.41 5.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.19 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.64 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -124.1 139.55 32.89 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.527 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -80.43 149.08 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.061 2.507 . . . . 0.0 112.297 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.508 ' HB3' ' OE2' ' A' ' 6' ' ' GME . 0.8 OUTLIER -86.58 58.38 5.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.918 0.866 . . . . 0.0 110.581 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.9 mt -125.5 -94.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.655 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -72.53 55.64 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.361 0.601 . . . . 0.0 111.092 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -178.9 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.554 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.25 58.3 0.12 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tt -62.14 116.0 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.682 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.4 -37.35 0.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.456 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 74.1 m -111.13 152.15 27.33 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.231 0.539 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 130.12 37.54 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.054 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.0 t -78.46 114.46 17.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.42 129.1 20.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 54.63 40.56 31.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.664 0.745 . . . . 0.0 110.715 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.044 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 61.9 mmtt 59.66 25.87 14.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.446 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.5 144.45 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 20' ' ' CYS . 71.4 m -89.37 134.69 33.97 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.598 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.21 153.27 48.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.871 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -152.33 144.24 23.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.017 179.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.3 pt -138.81 148.87 59.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.752 0.776 . . . . 0.0 109.804 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.82 142.0 61.37 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.864 1.709 . . . . 0.0 112.357 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.6 m -86.4 8.58 21.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.71 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.73 33.22 66.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.196 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -88.12 177.12 7.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.5 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 37.7 t -147.18 50.24 1.1 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.471 1.129 . . . . 0.0 108.639 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.648 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 25.7 t -78.9 -52.41 15.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.267 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -99.33 -60.26 1.56 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 pt -86.96 124.63 68.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.384 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.9 Cg_endo -86.13 129.03 3.27 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.708 2.272 . . . . 0.0 112.733 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -93.71 81.33 4.26 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.334 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.1 mm -124.96 -83.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 67.11 -62.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.635 1.174 . . . . 0.0 111.192 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 p -176.92 30.15 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.662 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.97 34.02 21.48 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.666 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 pt -107.0 -15.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.215 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -131.11 49.44 0.93 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 86.9 m 79.69 165.96 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.554 0.796 . . . . 0.0 110.696 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.5 127.14 49.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.98 124.52 24.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -145.44 129.9 17.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m 52.47 40.58 29.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.783 0.801 . . . . 0.0 110.986 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 17.5 mttm 56.62 31.52 19.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.292 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.07 149.06 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.3 m -89.09 134.38 34.02 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.584 0.707 . . . . 0.0 111.996 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -135.95 149.95 49.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.743 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -152.87 142.12 21.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.51 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.067 179.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 114.414 0.525 . . . . 0.0 114.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 pt -139.63 153.53 70.36 Favored Pre-proline 0 C--O 1.223 -0.305 0 CA-C-N 117.437 0.618 . . . . 0.0 109.386 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.28 143.71 71.62 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.826 1.684 . . . . 0.0 112.515 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.8 m -86.1 4.83 36.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.905 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.96 33.34 70.13 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.057 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -84.37 175.99 8.99 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.07 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 41.0 t -150.37 39.39 0.74 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.422 1.106 . . . . 0.0 108.096 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.068 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 27.0 t -79.31 -54.98 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.881 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -85.13 -44.85 12.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.747 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.531 HG13 ' HD2' ' A' ' 12' ' ' PRO . 11.7 tt -144.85 136.11 12.56 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.16 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 22.6 Cg_endo -62.8 161.46 28.84 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.97 2.446 . . . . 0.0 112.461 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -88.06 72.54 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.565 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -106.04 -130.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 14' ' ' ILE . 20.3 t 67.88 -62.59 0.34 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 111.14 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 m -158.69 16.05 0.19 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 43.35 1.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.506 0.669 . . . . 0.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 pt -63.26 98.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 158.5 -38.06 0.52 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.321 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -85.21 151.2 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.549 0.69 . . . . 0.0 110.488 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 m -122.15 134.01 54.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.205 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.58 127.11 31.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.08 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 23' ' ' LYS . 7.5 ttpp -154.01 128.91 9.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.974 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 m 55.37 42.46 30.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.413 0.625 . . . . 0.0 110.55 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 70.7 mmtt 59.18 28.07 17.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.852 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.44 141.01 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 91.4 m -89.29 137.36 32.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.27 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -130.79 155.63 46.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.377 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 50.8 ttp180 -153.02 142.29 21.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.665 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.138 179.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.5 pt -138.7 150.18 64.88 Favored Pre-proline 0 C--O 1.223 -0.295 0 CA-C-N 117.788 0.794 . . . . 0.0 109.491 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.38 145.36 98.29 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.006 1.804 . . . . 0.0 112.517 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 98.4 m -85.03 -47.22 10.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.605 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.98 -48.49 0.5 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.197 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 m -82.49 178.63 8.12 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.722 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 23.5 t -140.58 33.41 1.83 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.529 1.156 . . . . 0.0 107.966 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 25' ' ' LYS . 41.5 t -74.41 -47.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.951 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -89.72 -52.12 5.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.059 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.09 142.71 42.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.195 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 90.2 Cg_endo -80.98 159.88 20.92 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.07 2.513 . . . . 0.0 112.736 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 91.2 m -86.26 64.68 8.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.464 0.649 . . . . 0.0 110.058 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 16' ' ' SER . 7.7 pt -89.16 -114.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 m -69.66 33.58 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 14' ' ' ILE . 19.3 m -146.52 7.08 0.97 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.941 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . . . -174.21 53.47 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.6 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tt -57.94 108.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 122.0 0.905 . . . . 0.0 110.816 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.15 -33.04 1.37 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.017 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.5 m -95.61 152.7 18.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.592 0.71 . . . . 0.0 111.007 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -121.24 146.52 46.72 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.604 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.76 125.36 29.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.052 0.453 . . . . 0.0 110.716 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -144.23 124.49 13.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m 54.5 39.71 31.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.645 0.736 . . . . 0.0 110.243 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 8' ' ' CYS . 14.4 mmmm 57.08 34.3 24.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.317 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 60.7 t -143.35 148.28 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.3 m -87.76 133.86 33.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.42 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.27 155.55 46.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.475 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 56.1 ttp85 -152.71 139.71 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.417 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 113.163 0.025 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -134.2 135.31 23.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.81 141.13 93.9 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.053 1.836 . . . . 0.0 111.875 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.5 m -86.6 8.6 21.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.672 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.75 36.18 86.85 Favored Glycine 0 CA--C 1.509 -0.331 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.851 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -91.83 174.77 7.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.657 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 46.6 t -146.27 50.87 1.15 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.106 0.955 . . . . 0.0 108.984 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HD1' ' A' ' 10' ' ' TRP . 22.0 t -68.05 -41.9 84.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.386 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.555 ' HD1' HG12 ' A' ' 9' ' ' VAL . 17.4 m95 -139.96 -45.76 0.43 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.054 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.0 mm -70.95 127.49 91.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.054 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.97 155.11 71.13 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.08 2.52 . . . . 0.0 112.44 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 33.3 m -86.15 61.72 7.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.44 0.638 . . . . 0.0 111.22 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.2 mt -118.14 -54.25 4.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m 66.67 -51.75 0.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.935 1.397 . . . . 0.0 111.619 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 m -160.81 -39.64 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 167.14 47.32 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 O-C-N 124.147 0.904 . . . . 0.0 110.362 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 14' ' ' ILE . 27.8 pt -77.17 -29.48 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.318 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 42.63 52.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.378 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 87.5 m -97.08 152.03 19.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.277 0.561 . . . . 0.0 110.249 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.6 p -97.74 135.97 38.77 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.707 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.5 t -88.64 124.92 34.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 4.6 tmmm? -155.75 130.85 9.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.7 m 54.88 38.57 30.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.853 0.835 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 26.1 mmtp 56.18 30.79 17.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.638 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 26.3 m -142.17 146.28 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 61.2 m -89.25 136.99 32.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.502 0.667 . . . . 0.0 112.188 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.88 148.51 40.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 48.1 ttp85 -152.37 138.26 18.06 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 7.4 m120 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.939 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 113.484 0.153 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.94 136.22 22.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 28' ' ' TYR . 36.0 Cg_exo -58.3 143.5 97.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 121.877 1.718 . . . . 0.0 112.581 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.5 m -84.98 -42.64 14.72 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.123 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.11 -41.63 1.38 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.092 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.11 174.79 9.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.93 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 46.1 t -150.65 54.21 0.89 Allowed 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 21.0 t -65.83 -40.47 87.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.362 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 9' ' ' VAL . 66.8 m95 -139.74 -51.28 0.51 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.49 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.0 120.92 83.1 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 73.8 Cg_endo -74.91 141.09 26.51 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.758 2.305 . . . . 0.0 112.029 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.6 p -87.84 63.98 7.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.544 0.687 . . . . 0.0 111.535 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' SER . 57.7 mt -102.27 -78.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.661 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m 51.98 3.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.13 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' ILE . 20.9 m 62.04 26.15 15.74 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.961 0.505 . . . . 0.0 110.079 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.71 47.47 0.05 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.514 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.726 HG21 ' HB2' ' A' ' 13' ' ' CYS . 38.2 mm -129.87 -48.99 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.126 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.0 45.4 51.22 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.019 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 92.1 m -139.9 151.35 45.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.335 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.0 m -102.13 130.71 48.81 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.219 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.5 t -81.5 127.88 33.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.846 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 ttmt -161.94 134.77 6.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 53.2 40.21 30.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.238 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 51.8 mttp 59.27 29.55 19.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.942 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 p -150.17 145.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 55.7 m -89.67 137.17 32.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 0.0 111.636 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 3' ' ' PRO . 4.3 m-85 -130.38 158.53 39.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.961 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 35.0 ttm180 -150.37 132.27 15.13 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.458 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.247 179.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 114.467 0.547 . . . . 0.0 114.467 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 pt -136.39 154.37 76.95 Favored Pre-proline 0 C--O 1.221 -0.438 0 CA-C-N 117.665 0.732 . . . . 0.0 109.156 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.12 144.38 81.47 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 121.584 1.523 . . . . 0.0 112.758 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 81.9 m -85.33 3.8 38.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.65 32.05 67.5 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.414 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.34 173.71 9.53 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.33 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 43.1 t -150.29 52.51 0.9 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.15 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.4 t -88.32 -42.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.65 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -99.77 -48.15 4.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.262 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 pt -137.02 141.8 36.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.03 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 66.4 Cg_endo -75.08 148.52 35.11 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.089 2.526 . . . . 0.0 112.404 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 60.07 5.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.377 0.608 . . . . 0.0 110.577 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 12' ' ' PRO . 45.8 mm -95.29 -64.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m -70.06 21.76 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.379 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 24.6 m -154.91 14.29 0.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.46 60.42 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.278 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 pt -52.51 110.78 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.153 0.978 . . . . 0.0 111.296 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' HE ' ' A' ' 29' ' ' ARG . . . 129.05 -28.21 4.15 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.502 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 91.1 m -73.5 148.25 43.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.775 0.797 . . . . 0.0 110.996 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -121.39 134.24 55.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.699 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.97 125.53 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.401 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 2.6 ptmm? -152.65 128.11 9.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.787 0.327 . . . . 0.0 110.531 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m 55.93 40.88 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 110.766 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.3 mtmt 61.34 26.1 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.749 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.03 139.78 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 82.6 m -89.49 138.85 31.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.235 0.54 . . . . 0.0 111.603 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -129.8 152.57 49.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.442 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.677 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt-85 -151.79 138.27 18.61 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.913 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.455 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.41 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.5 mt -137.25 137.27 22.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.02 144.29 90.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 121.904 1.736 . . . . 0.0 112.197 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.79 -39.05 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.324 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.92 -46.74 0.41 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.402 -1.38 . . . . 0.0 113.429 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.461 ' H2X' ' SG ' ' A' ' 13' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.4 m -77.6 -177.69 4.91 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.753 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 36.0 t -140.01 48.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.475 1.131 . . . . 0.0 108.299 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.74 -40.99 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.657 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -93.84 -52.64 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.166 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 HG13 ' H1X' ' A' ' 6' ' ' GME . 16.3 pt -144.94 141.98 18.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' ILE . 59.2 Cg_endo -73.25 148.76 44.4 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.775 2.316 . . . . 0.0 112.008 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' H2X' ' A' ' 6' ' ' GME . 5.1 m -86.36 60.28 6.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.287 0.565 . . . . 0.0 110.296 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 12' ' ' PRO . 46.1 mm -97.11 -70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m -70.72 22.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.334 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 14' ' ' ILE . 22.9 m -154.59 15.85 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 58.46 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -50.76 106.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 29' ' ' ARG . . . 135.3 -31.54 2.67 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.439 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.7 m -75.73 152.71 37.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.59 0.71 . . . . 0.0 110.834 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -127.81 143.58 51.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -82.8 125.05 30.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -147.52 130.42 16.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.152 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 m 53.4 40.09 30.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.571 0.7 . . . . 0.0 110.938 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 58.64 32.02 21.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.794 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 47.3 t -144.4 148.23 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.0 m -88.8 132.62 34.56 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.978 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.72 155.15 50.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.756 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 67.7 ttt180 -151.36 136.29 17.32 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.659 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.581 179.83 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 113.427 0.131 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -137.98 133.99 17.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.63 141.01 94.01 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.062 1.842 . . . . 0.0 112.036 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.8 m -86.81 11.81 12.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.671 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.46 30.01 73.13 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.867 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.0 175.82 7.25 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.112 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.664 ' SG ' ' HA ' ' A' ' 12' ' ' PRO . 39.5 t -142.34 41.36 1.62 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 123.018 1.39 . . . . 0.0 107.312 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.791 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 51.6 t -83.45 -52.85 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 114.009 -1.45 . . . . 0.0 111.768 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -84.41 -49.55 8.58 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.305 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -132.52 142.22 44.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.281 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.664 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 84.4 Cg_endo -78.58 142.75 18.53 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.891 2.394 . . . . 0.0 111.755 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -87.59 56.57 3.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.696 . . . . 0.0 111.564 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.738 HG13 ' H ' ' A' ' 15' ' ' SER . 2.9 pt -117.81 -68.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.272 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.738 ' H ' HG13 ' A' ' 14' ' ' ILE . 7.0 m -70.02 34.56 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.286 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 14' ' ' ILE . 13.4 m -139.4 5.65 2.27 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.96 29.04 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.623 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' SER . 50.8 mm -77.81 -35.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.13 39.63 18.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.757 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.39 154.79 48.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 0.0 110.245 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -98.86 130.18 45.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -81.74 114.02 20.11 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.15 129.96 34.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.3 m 55.59 36.31 26.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.911 0.862 . . . . 0.0 109.805 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.791 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 26.2 mtpp 57.52 34.86 25.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.684 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.19 142.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.1 m -89.14 133.8 34.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.557 0.694 . . . . 0.0 111.795 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -137.93 152.81 49.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.505 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' ASN . 7.3 tmm_? -151.76 134.52 15.58 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.638 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 18.6 t30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 113.478 0.151 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.45 134.21 25.79 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.11 141.39 93.69 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.997 1.798 . . . . 0.0 112.087 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -86.0 3.27 42.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.624 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.66 38.08 77.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.54 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.527 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.86 173.5 8.21 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.985 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.52 51.27 0.94 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.017 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 15.7 t -67.03 -41.96 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.435 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.443 ' CD1' HG12 ' A' ' 9' ' ' VAL . 76.6 m95 -140.9 -49.58 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.187 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.7 pt -73.29 137.9 78.43 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.112 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 162.19 40.8 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.758 2.305 . . . . 0.0 111.837 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 32.7 m -85.62 57.73 4.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.446 0.641 . . . . 0.0 110.854 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 39.0 mm -116.49 -53.19 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.789 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.5 m 66.15 -49.6 0.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.409 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.4 t -178.99 -25.27 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.81 53.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 20' ' ' CYS . 67.2 mt -131.45 142.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -122.45 40.48 2.03 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.323 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 69.5 m -75.67 152.15 37.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.702 0.763 . . . . 0.0 110.545 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 m -93.19 133.93 35.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.525 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 t -81.5 127.47 32.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.6 tmmm? -143.31 116.96 9.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 m 52.12 43.11 30.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.418 0.627 . . . . 0.0 110.855 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 65.5 mttm 60.06 32.26 20.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.804 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -138.66 140.91 38.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 60.5 m -87.54 138.43 31.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.435 0.636 . . . . 0.0 111.862 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -138.43 153.3 48.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.121 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.5 tpm_? -151.38 133.47 15.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.292 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.436 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.81 148.98 57.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 117.596 0.698 . . . . 0.0 109.626 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.35 143.28 76.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.927 1.751 . . . . 0.0 112.596 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.3 m -86.28 5.69 33.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.387 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.7 38.74 67.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.677 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.43 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -90.19 175.23 7.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.483 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -150.66 49.83 0.87 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.638 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 25' ' ' LYS . 21.4 t -76.3 -35.27 27.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.389 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -135.78 -49.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.922 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' HD2' ' A' ' 12' ' ' PRO . 5.4 tp -77.33 120.9 83.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.619 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD12 ' A' ' 11' ' ' ILE . 21.2 Cg_exo -66.93 157.15 62.97 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.769 2.313 . . . . 0.0 112.124 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.54 62.98 7.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.402 0.62 . . . . 0.0 110.22 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 16' ' ' SER . 60.0 mt -133.9 -75.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.772 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -60.32 5.24 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 14' ' ' ILE . 47.1 m -158.82 18.99 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.728 0.299 . . . . 0.0 110.263 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -169.33 53.61 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -56.3 115.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.98 0.895 . . . . 0.0 110.802 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.17 -23.16 25.8 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.47 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.44 150.06 31.39 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.631 0.729 . . . . 0.0 111.061 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -108.85 138.99 44.3 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.058 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -85.17 125.86 33.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -154.43 131.84 11.23 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m 52.41 41.8 30.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.456 0.646 . . . . 0.0 111.518 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 9' ' ' VAL . 99.0 mttt 58.92 28.86 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.561 -1.2 . . . . 0.0 113.009 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 13.7 m -146.31 150.37 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 63.0 m -89.62 135.79 33.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.248 0.547 . . . . 0.0 111.428 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.71 147.94 47.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.391 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -152.9 143.32 22.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.533 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.313 -1.016 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.953 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.5 pt -142.72 154.35 62.58 Favored Pre-proline 0 C--O 1.223 -0.318 0 CA-C-N 117.523 0.661 . . . . 0.0 109.319 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.73 145.44 86.56 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.775 1.65 . . . . 0.0 112.552 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.68 -48.83 9.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.328 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.24 -46.42 0.72 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.015 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.654 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.32 175.62 7.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.36 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.3 t -151.13 45.14 0.82 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.913 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 11.3 t -72.86 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.997 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.408 ' HD1' HG12 ' A' ' 9' ' ' VAL . 21.0 m95 -96.2 -50.38 4.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.213 0.53 . . . . 0.0 109.795 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.71 146.09 72.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.68 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 168.31 15.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.909 2.406 . . . . 0.0 111.624 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.0 t -85.84 65.75 9.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.679 0.752 . . . . 0.0 110.494 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 18' ' ' ILE . 46.5 mm -123.67 -79.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 m 64.91 -64.41 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.788 1.235 . . . . 0.0 111.645 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.3 t 178.58 31.57 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.536 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.79 68.27 0.4 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 14' ' ' ILE . 40.2 mt -65.52 95.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -177.52 41.23 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.7 m -151.79 154.44 36.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.895 0.378 . . . . 0.0 110.169 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -101.82 127.75 48.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.951 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.8 t -74.07 119.14 17.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -142.47 129.34 20.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 54.07 39.78 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.597 0.713 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.913 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 2.8 mptp? 59.12 28.72 18.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.415 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.1 152.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.654 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 74.0 m -87.1 136.1 33.05 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.01 147.08 50.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.273 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 73.2 ttt180 -153.22 144.85 23.4 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.22 179.718 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.593 0 N-CA-C 113.519 0.168 . . . . 0.0 113.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.0 mm -134.76 134.99 22.52 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.41 141.12 85.82 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.907 1.738 . . . . 0.0 112.524 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 84.4 m -86.51 0.49 54.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.27 32.95 72.57 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.905 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -92.9 176.1 6.55 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.196 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 52.1 t -150.11 49.78 0.91 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.129 0.966 . . . . 0.0 108.683 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.898 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 21.3 t -70.4 -47.0 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.722 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.652 ' HD1' HG12 ' A' ' 9' ' ' VAL . 19.4 m95 -136.23 -50.43 0.69 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.93 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.17 123.23 88.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.571 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.14 149.02 63.87 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.748 2.298 . . . . 0.0 112.065 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.8 m -86.89 79.95 8.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 110.634 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -125.93 -64.69 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.594 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 67.46 -48.28 0.5 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 124.914 1.384 . . . . 0.0 111.787 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 12.1 p -175.86 -35.07 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.381 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' SER . . . 170.16 52.93 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.351 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.41 -31.39 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.739 0.304 . . . . 0.0 111.155 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 55.78 6.01 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.938 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.1 m -138.67 153.12 48.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.812 0.339 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.5 m -103.46 132.18 49.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.0 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -86.09 126.3 34.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.17 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -154.16 130.05 10.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 52.81 41.48 31.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.622 0.725 . . . . 0.0 111.374 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.898 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 60.52 28.23 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.141 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.88 146.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 m -107.28 137.56 45.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.016 0.913 . . . . 0.0 112.97 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.556 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.416 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 20.9 ttm180 -150.85 136.2 17.79 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.063 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.311 -1.067 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.448 -179.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 114.113 0.405 . . . . 0.0 114.113 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.8 tp -150.32 141.55 14.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.6 Cg_endo -57.22 145.0 89.16 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 121.987 1.791 . . . . 0.0 112.842 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 99.2 m -84.31 -35.2 23.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.76 -35.13 3.52 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.279 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 175.72 10.13 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.695 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 42.0 t -148.03 50.77 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.804 0.812 . . . . 0.0 109.045 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 25' ' ' LYS . 21.5 t -87.21 -39.74 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 9.6 m-90 -119.06 -50.34 2.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.186 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.1 mm -90.7 116.16 65.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.415 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 98.6 Cg_endo -80.99 144.52 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 112.268 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 82.6 m -87.21 60.15 5.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.488 0.661 . . . . 0.0 111.022 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 12' ' ' PRO . 19.4 mt -104.01 -116.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.892 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -71.91 33.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.238 0.542 . . . . 0.0 111.731 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 14' ' ' ILE . 16.4 m -147.38 4.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.464 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -167.93 50.66 0.05 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.272 0.558 . . . . 0.0 109.928 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -53.54 122.58 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.289 1.042 . . . . 0.0 111.131 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA3' ' NH1' ' A' ' 29' ' ' ARG . . . 124.49 -37.52 2.6 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 96.2 m -93.63 150.85 20.09 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.428 0.632 . . . . 0.0 110.047 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.7 p -115.8 135.13 54.31 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.124 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.83 124.09 27.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -152.75 127.61 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.411 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p 47.26 46.83 16.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.211 0.529 . . . . 0.0 112.354 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.767 ' HB3' HG22 ' A' ' 9' ' ' VAL . 48.3 mtmt 63.32 25.19 14.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.254 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.59 142.05 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 65.9 m -92.48 139.23 30.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 112.405 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.26 157.7 34.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.739 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.2 ttm-85 -150.59 138.11 19.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.811 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.8 t30 . . . . . 0 C--N 1.307 -1.247 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.635 179.301 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 114.627 0.611 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.5 pt -141.73 148.92 51.61 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 117.892 0.846 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 28' ' ' TYR . 31.6 Cg_endo -65.31 140.9 66.17 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.129 1.886 . . . . 0.0 112.512 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.23 -27.11 24.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.268 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.0 -28.39 13.21 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.595 ' H1G' ' HB2' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.87 171.72 11.29 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.133 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t -150.45 44.84 0.87 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.223 1.011 . . . . 0.0 108.418 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.876 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 16.2 t -69.81 -42.9 80.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.695 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -128.11 -52.45 1.31 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.0 119.07 71.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 93.4 Cg_endo -81.75 147.89 15.54 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.851 2.367 . . . . 0.0 111.787 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.2 m -86.59 53.13 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.529 0.681 . . . . 0.0 110.651 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' SER . 62.1 mt -100.1 -70.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.724 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 m -69.07 19.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.964 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' ILE . 42.2 t -102.19 -18.39 15.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.52 40.62 31.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.804 0.812 . . . . 0.0 110.949 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.764 HG23 ' H ' ' A' ' 20' ' ' CYS . 8.8 tp -90.78 -18.01 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.794 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.54 -14.54 62.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.183 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.764 ' H ' HG23 ' A' ' 18' ' ' ILE . 84.6 m -77.5 152.38 34.16 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.523 0.677 . . . . 0.0 110.582 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.3 p -117.64 136.22 53.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.417 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.58 129.56 40.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -151.13 121.05 7.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 54.01 43.01 31.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.609 0.718 . . . . 0.0 111.092 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.05 23.77 14.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.642 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -141.02 138.97 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' H1G' ' A' ' 6' ' ' GME . 78.6 m -89.67 133.78 34.48 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.969 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 3' ' ' PRO . 4.4 m-85 -124.91 153.61 42.39 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.403 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -152.36 142.1 21.93 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.312 -1.032 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.078 179.702 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.746 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.5 pt -132.86 148.38 69.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 118.024 0.912 . . . . 0.0 109.994 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.29 145.7 98.13 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.186 1.924 . . . . 0.0 112.573 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 93.9 m -84.15 -47.88 10.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.428 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.01 -47.13 0.65 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.23 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . 0.659 ' H1G' ' SG ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.99 176.88 8.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -147.76 46.52 1.1 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.199 0.999 . . . . 0.0 108.606 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.897 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 t -74.33 -62.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.803 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -96.23 -56.46 2.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.185 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.56 123.83 88.65 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.03 132.45 16.82 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.551 2.168 . . . . 0.0 112.321 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.43 73.14 8.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.36 -40.6 13.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.77 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m 51.96 7.71 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.213 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 m 65.09 32.96 9.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.99 0.516 . . . . 0.0 110.556 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.95 43.76 26.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.875 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 tt -159.75 43.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.406 1.098 . . . . 0.0 110.05 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -165.75 -72.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.865 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.1 m -152.28 158.16 42.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -115.81 132.02 56.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.701 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 t -68.26 134.04 49.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.835 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -156.3 127.35 6.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 p 49.92 43.22 25.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.616 0.722 . . . . 0.0 111.435 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.897 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 3.7 mptp? 58.44 30.48 19.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.564 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -143.38 154.54 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.659 ' SG ' ' H1G' ' A' ' 6' ' ' GME . 84.3 m -87.26 136.49 32.91 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -132.41 154.38 49.88 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.501 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 46.9 ttp180 -151.67 136.49 17.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.593 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.951 -179.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 113.528 0.171 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 3' ' ' PRO . 7.3 tp -150.25 141.0 14.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 2' ' ' ILE . 26.8 Cg_endo -64.12 141.19 75.3 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.938 1.759 . . . . 0.0 112.571 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.0 m -86.28 -45.09 11.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.6 -40.81 1.48 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.178 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -91.57 166.01 13.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.914 178.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 22.1 p -135.06 39.59 2.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.326 0.584 . . . . 0.0 110.667 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 25' ' ' LYS . 26.3 t -76.77 -50.52 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -88.39 -51.17 5.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.203 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.3 tt -105.57 110.43 64.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.863 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 98.2 Cg_endo -79.62 125.57 6.26 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.286 1.991 . . . . 0.0 113.127 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 1.8 p -89.61 78.32 7.03 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.54 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 16' ' ' SER . 58.5 mt -114.23 -36.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.151 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -41.51 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.286 1.834 . . . . 0.0 114.019 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' ILE . 19.4 m 58.17 24.7 11.66 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.3 32.9 6.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.62 -38.61 76.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.686 0.755 . . . . 0.0 109.064 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' CYS . . . -103.99 38.49 3.22 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 63.0 m 78.28 164.61 0.22 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.514 0.773 . . . . 0.0 110.293 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -64.82 128.83 37.42 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -154.85 123.84 6.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.737 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 m 54.0 44.55 29.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 67.78 10.62 7.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.285 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 8.6 m -137.56 153.19 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.819 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 65.0 m -87.77 137.0 32.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.476 0.655 . . . . 0.0 111.28 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -127.62 154.7 44.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 112.185 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.0 ttm180 -151.3 141.53 22.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.17 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.219 179.212 . . . . . . . . 0 0 . 1 stop_ save_